Issues to ensure transparency and control in the drug distribution chain in Greece

10 July 2023
greece_athens_large

Regarding the Greek National Organization for Medicines (EOF) announcement on the issue of shortages, the trade group Hellenic Association of Pharmaceutical Companies (SFEE) has issued its views. It emphasized the following points:

The issue of shortages of medicines is a global phenomenon with many dimensions. The European pharmaceutical strategy, which has been discussed for two-three years in Brussels, has put the issue of medicine shortages at the heart of its initiatives, but without proposing sustainable and substantial solutions to tackle the problem.

In Greece, the issue is even more complex because, apart from the lack of raw materials and active substances that affect the factories, there is also the issue of parallel exports of mainly innovative medicines, which is due to very low prices compared to other European countries. For example, these prices in the local market are around 1/4 or 1/5 of the price of the same drugs in Germany and this huge profit margin pushes some Greek wholesalers to prefer exports.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical